Buxton: drug development Flashcards

1
Q

pharmacy

A

broad discipline interested in MANUFACTURE and therapeutic management of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

safety pharmacology

A

focuses on finding side effects BEFORE drugs go on market

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

toxicology

A

adding environmental/industrial stressors to the point that does does damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

generic name

A

assigned to a drug (NOT BRAND.) ex, propanolo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

chemical name

A

IUPAC name

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

lead drug

A

compound w/ greatest POTENTIAL for development… then it gets tested

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

official drug names

A

name in databases (us pharmacopia, national formulary, us adopted names)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

trade name

A

name marketed by company

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

FDA

A
  • regulates drugs for human consumption
  • FDA website has recall and safety alerts
  • it’s not perfect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

chinese papyrus

A

used to treat smallpox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how many proposed chemical entities actually become drugs

A

1 in 10K :O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

omparozol (sp?)

A

made an isomer that works just as well just to not waste money of drug developement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

drug development timeline

don’t need to know too well, just the gist

A
at bench, 1-5 yrs. 
-then market analysis
and then go through the lead finding
-then pharmacologic eval: find in vitro receptor, cell assay, animal models
-then select candidates
-then toxicology and pharacokinetics
-then select candidates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Investigational new drug app

A

studies chemical and biological activities; doses specified for humans; quality control; description of company facilities; scientific qualifications of investigators; specific details of protocol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

clinical testing protocols

A

objectives, methods, controls for age gender sex and such

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

phase I

A

20-100 healthy volunteers. look for safety, beset way to administrator, evaluate how drug is metabolized… COLLEGE KIDS perfect for this

6-8mo

17
Q

phase II

A

30-40 control and diseased subjects… 1/5 respond, then it’s considered successful. then you establish dose range. see long term toxicity

6mo-3yr

18
Q

phase III

A

1-4 yrs. 100-1000+ volunteers suffering from condition. determine whether the drug is effective and safe

19
Q

if drug is safe and effective after phase three…?

A

submit new drug app to FDA to approval

test fertility and long term toxcitty

20
Q

phase IIIb/IV

A

on going time! volunteer patients. provides additional safety data, applies to broad pop. no longer blind studies

21
Q

post/market studies

A

ongoing, months to years.
new age groups or patient types.
continues safety assurance and checks for unknown side effects

22
Q

three agencies for drug development

A

US: FDA
European: Organization of economic cooperation and development, OECD
Japanese Agency: ministry of health labor and welfare-MHLW

23
Q

GLP

A

Good lab practices to make sure experiments date is collected well and stuff

24
Q

Thalidomide

A

morning sickness pill used in europe

sadly, FDA recognized that it caused severe birth defects in newbords

25
Q

TGN1412

A
  • antibody to help balance immune system’s T cells
  • worked well in monkey (no observed effect level) but cause terrible cytokine storm in humans-
  • things we learned: we gotta know mechanism, don’t administer simultaneuously to pts, and healty vs patients should be reevaluated